Owner Abbott Laboratories

Inventors Sorensen, Bryan K.; Yong, Hong; Link, James T.; Rohde, Jeffrey J.; Yeh, Vince S.; Patel, Jyoti R.; Winn, Martin; Shuai, Qi; Dinges, Jurgen

Agent Spruson & Ferguson

Pub. Number AU-A-2011253958

Parent 2006204017

Filing date 12 December 2011

Wipo publication date 12 January 2012

C07C 235/14 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07C 317/16 (2006.01) Sulfones

C07C 323/41 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 207/48 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms